Effectiveness of a Mindfulness and Compassion Intervention for Pregnant Women and Their Partners for the Prevention of Stress and Depression During Pregnancy and Breastfeeding

December 1, 2019 updated by: Javier Garcia Campayo

Effectiveness of a Mindfulness and Compassion Group Intervention Applied to Pregnant Women and Their Partners to Decrease Stress, Negative Affect and Depression During Pregnancy and Breastfeeding. Controlled and Randomized Study

The aim of this study is to assess a mindfulness and compassion group intervention for pregnant women and their partners (8 weeks) for the prevention, reduction and treatment of stress, negative affect and depression in pregnancy and breastfeeding. This group intervention will also be compared with a Treatment as usual (TAU) group consisting in a childbirth education class taught by the Health Center midwife. The principal hypothesis is that the mindfulness and compassion intervention will be more effective than TAU.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The aim of this study is to assess a mindfulness and compassion group intervention for pregnant women and their partners (8 weeks) for the prevention, reduction and treatment of stress, negative affect and depression in pregnancy and breastfeeding.

There will be two groups:

  1. A face to face mindfulness and compassion intervention for pregnant women in their second trimester of pregnancy and their partners in group format (8 weeks) based in the Mindfulness Based Childbirth and Parenting program from Nancy Bardacke. This group will also receive in their third trimester of pregnancy the childbirth education classes taught by midwives (6-8 weeks) that every pregnant woman normally attends to in the National Health Care System in Spain (TAU).
  2. A control group that will receive only the childbirth education class by midwives (TAU) group consisting in a childbirth education class taught by the Health Center midwife at the third trimester of pregnancy.

Each group will be composed of 60 participants with a total sample of 120. The principal hypothesis is that the mindfulness and compassion intervention will be more effective than TAU in the decrease of stress, negative affect and depression and in the increase of positive affect during pregnancy and breastfeeding.

The differences between the intervention and control group will be analyzed. Finally, a qualitative study will be conducted.

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valladolid, Spain, 47013
        • Universidad Nacional de Educación a Distancia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Be at least 18 years old
  • Willingness to participate in the study and signing informed consent
  • Ability to understand and write Spanish.
  • Women will be in their 6 to 25 weeks of pregnancy.
  • All women eligible will be accepted with our without their partner.

Exclusion Criteria:

  • Any diagnose of disease that may affect central nervous system (brain pathology, traumatic brain injury, dementia, etc.),
  • Other psychiatric diagnoses or acute psychiatric illness (substance dependence or abuse, history of schizophrenia or other psychotic disorders, eating disorders, etc.),
  • Any medical, infectious or degenerative disease that may affect mood, presence of delusional ideas or hallucinations consistent or not with mood, and suicide risk
  • Currently taking psychopharmacological medication or under psychopharmacological treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
TAU + mindfulness applied face to face 8 sessions of 120 minutes/session Mindfulness and Compassion based intervention applied in groups of 12-15 people in traditional format. Written material and sound recordings will be offered as support elements. The estimated duration of the face to face program is two months.
TAU + mindfulness applied face to face 8 sessions of 120 minutes/session Mindfulness and Compassion based intervention applied in groups of 12-15 people in traditional format. Written material and sound recordings will be offered as support elements. The estimated duration of the face to face program is two months.
No Intervention: No intervention
Usual medical treatment (TAU) In this group the midwife will apply the usual treatment (childbirth education class in the third trimester of pregnancy).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Edinburgh postnatal depression scale (EPDS)
Time Frame: Baseline
In the mindfulness and compassion based intervention group
Baseline
Edinburgh postnatal depression scale (EPDS)
Time Frame: Baseline
In the TAU control group
Baseline
Edinburgh postnatal depression scale (EPDS)
Time Frame: Post-treatment 8 weeks from baseline in intervention group
Post-treatment 8 weeks from baseline in intervention group
Edinburgh postnatal depression scale (EPDS)
Time Frame: Post-treatment 8 weeks from baseline in TAU control group
Post-treatment 8 weeks from baseline in TAU control group
Edinburgh postnatal depression scale (EPDS)
Time Frame: Post-partum 3 months follow up in 8 weeks intervention group
Post-partum 3 months follow up in 8 weeks intervention group
Edinburgh postnatal depression scale (EPDS)
Time Frame: Post-partum 3 months follow up in TAU control group
Post-partum 3 months follow up in TAU control group
Edinburgh postnatal depression scale (EPDS)
Time Frame: Post-partum 6 months follow up in 8 weeks intervention group
Post-partum 6 months follow up in 8 weeks intervention group
Edinburgh postnatal depression scale (EPDS)
Time Frame: Post-partum 6 months follow up in TAU control group
Post-partum 6 months follow up in TAU control group

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic data Gender, age, marital status, education, occupation, economical level
Time Frame: Baseline
In the mindfulness-based intervention applied face-to-face and TAU control group
Baseline
M.I.N.I. International Neuropsychiatric Interview
Time Frame: baseline applied in TAU and in intervention group
only if needed
baseline applied in TAU and in intervention group
Client service receipt inventory (CSRI)
Time Frame: Baseline
In the mindfulness-based intervention applied face-to-face and TAU control group
Baseline
Client service receipt inventory (CSRI)
Time Frame: Post-partum 6 months follow up in 8 weeks intervention group
Post-partum 6 months follow up in 8 weeks intervention group
Client service receipt inventory (CSRI)
Time Frame: Post-partum 6 months follow up in TAU control group
Post-partum 6 months follow up in TAU control group
Medical data regarding delivery and breastfeeding
Time Frame: 2 months after delivery
In the mindfulness-based intervention applied face-to-face and TAU control group
2 months after delivery
Perceived Stress Scale (PSS)
Time Frame: Baseline
In the mindfulness and compassion based intervention group
Baseline
Perceived Stress Scale (PSS)
Time Frame: Baseline
In the TAU control group
Baseline
Perceived Stress Scale (PSS)
Time Frame: Post-treatment 8 weeks from baseline in 8 weeks intervention group
Post-treatment 8 weeks from baseline in 8 weeks intervention group
Perceived Stress Scale (PSS)
Time Frame: Post-treatment 8 weeks from baseline in TAU control group
Post-treatment 8 weeks from baseline in TAU control group
Perceived Stress Scale (PSS)
Time Frame: Post-partum 3 months follow up in 8 weeks intervention group
Post-partum 3 months follow up in 8 weeks intervention group
Perceived Stress Scale (PSS)
Time Frame: Post-partum 3 months follow up in TAU control group
Post-partum 3 months follow up in TAU control group
Perceived Stress Scale (PSS)
Time Frame: Post-partum 6 months follow up in 8 weeks intervention group
Post-partum 6 months follow up in 8 weeks intervention group
Perceived Stress Scale (PSS)
Time Frame: Post-partum 6 weeks follow up in TAU control group
Post-partum 6 weeks follow up in TAU control group
Positive and negative affect (PANAS)
Time Frame: Baseline
In the mindfulness and compassion based intervention group
Baseline
Positive and negative affect (PANAS)
Time Frame: Baseline
In the TAU control group
Baseline
Positive and negative affect (PANAS)
Time Frame: Post-treatment 8 weeks from baseline in 8 weeks intervention group
Post-treatment 8 weeks from baseline in 8 weeks intervention group
Positive and negative affect (PANAS)
Time Frame: Post-treatment 8 weeks from baseline in TAU control group
Post-treatment 8 weeks from baseline in TAU control group
Positive and negative affect (PANAS)
Time Frame: Post-partum 3 months follow up in 8 weeks intervention group
Post-partum 3 months follow up in 8 weeks intervention group
Positive and negative affect (PANAS)
Time Frame: Post-partum 3 months follow up in TAU control group
Post-partum 3 months follow up in TAU control group
Positive and negative affect (PANAS)
Time Frame: Post-partum 6 months follow up in 8 weeks intervention group
Post-partum 6 months follow up in 8 weeks intervention group
Positive and negative affect (PANAS)
Time Frame: Post-partum 6 months follow up in TAU control group
Post-partum 6 months follow up in TAU control group
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Baseline
In the mindfulness and compassion based intervention group
Baseline
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Baseline
In the TAU control group
Baseline
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Post-treatment 8 weeks from baseline in 8 weeks intervention group
Post-treatment 8 weeks from baseline in 8 weeks intervention group
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Post-treatment 8 weeks from baseline in TAU control group
Post-treatment 8 weeks from baseline in TAU control group
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Post-partum 3 months follow up in 8 weeks intervention group
Post-partum 3 months follow up in 8 weeks intervention group
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Post-partum 3 months follow up in TAU control group
Post-partum 3 months follow up in TAU control group
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Post-partum 6 months follow up in 8 weeks intervention group
Post-partum 6 months follow up in 8 weeks intervention group
Five Facets and factors of mindfulness (FFMQ)
Time Frame: Post-partum 6 months follow up in TAU control group
Post-partum 6 months follow up in TAU control group
Self Compassion Scale (SCS)
Time Frame: Baseline
In the mindfulness and compassion based intervention group
Baseline
Self Compassion Scale (SCS)
Time Frame: Baseline
In the TAU control group
Baseline
Self Compassion Scale (SCS)
Time Frame: Post-treatment 8 weeks from baseline in 8 weeks intervention group
In the mindfulness and compassion based intervention group
Post-treatment 8 weeks from baseline in 8 weeks intervention group
Self Compassion Scale (SCS)
Time Frame: Post-treatment 8 weeks from baseline in TAU control group
Post-treatment 8 weeks from baseline in TAU control group
Self Compassion Scale (SCS)
Time Frame: Post-partum 3 months follow up in 8 weeks intervention group
Post-partum 3 months follow up in 8 weeks intervention group
Self Compassion Scale (SCS)
Time Frame: Post-partum 3 months follow up in TAU control group
Post-partum 3 months follow up in TAU control group
Self Compassion Scale (SCS)
Time Frame: Post-partum 6 months follow up in 8 weeks intervention group
Post-partum 6 months follow up in 8 weeks intervention group
Self Compassion Scale(SCS)
Time Frame: Post-partum 6 months follow up in TAU control group
Post-partum 6 months follow up in TAU control group
Parental Evaluation Scale (EEP)
Time Frame: Post-partum 3 months follow up in 8 weeks intervention group
Post-partum 3 months follow up in 8 weeks intervention group
Parental Evaluation Scale (EEP)
Time Frame: Post-partum 3 months follow up in TAU control group
Post-partum 3 months follow up in TAU control group
Parental Evaluation Scale (EEP)
Time Frame: Post-partum 6 months follow up in 8 weeks intervention group
Post-partum 6 months follow up in 8 weeks intervention group
Parental Evaluation Scale (EEP)
Time Frame: Post-partum 6 months follow up in TAU control group
Post-partum 6 months follow up in TAU control group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2017

Primary Completion (Actual)

October 2, 2019

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

August 9, 2017

First Submitted That Met QC Criteria

August 9, 2017

First Posted (Actual)

August 11, 2017

Study Record Updates

Last Update Posted (Actual)

December 3, 2019

Last Update Submitted That Met QC Criteria

December 1, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 50/2014/04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy, Childbirth and Postpartum

Clinical Trials on Mindfulness

3
Subscribe